It was reduced with the application of miR-518d inhibitors, and was increased with the knockdown of PPARα. This suggests that the development of GDM might be associated with an inflammatory response in the placenta which is regulated by miR-518d through the inhibition of PPARα and the activation of NF-κB. The gene discussed is NFKB1; the disease is gestational diabetes.